NCT01818089

Brief Summary

The aim of this study is to investigate if any correlation between lung sounds of pneumonia patients and the clinical development or therapy of the pneumonia exists.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 15, 2013

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 26, 2013

Completed
6 days until next milestone

Study Start

First participant enrolled

April 1, 2013

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2014

Completed
Last Updated

September 23, 2015

Status Verified

September 1, 2015

Enrollment Period

10 months

First QC Date

February 15, 2013

Last Update Submit

September 22, 2015

Conditions

Pneumonia

Outcome Measures

Primary Outcomes (1)

  • Sound of lungs

    3 times a day for longest 5 days

    5 days

Study Arms (1)

Lung Sound Analyzer

Patient with pneumonia admitted to hospital will receive additional auscultation with lung sound analyzing stethoscope

Device: Lung sound analyzer

Interventions

Lung sound analyzerDEVICE

Patients will be aucultated with lung sound analyzer. The auscultation will be done three times daily during the duration of the complete hospital stay.

Also known as: Electronic stethoscope, Model 3200, Littmann 3M
Lung Sound Analyzer

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with ambulant aquired pneumonia

You may qualify if:

  • ambulant aquired pneumonia with typically radiological signs
  • hospitalisation at medical clinic I, university hospital Aachen
  • age at least \> 18 years
  • CRB-65 score \> 1
  • CRP\> 60mg/l
  • fever
  • lung sounds audible by stethoscope
  • legal capacity and being able to understand and to follow the instructions of the study staff
  • being able to consent and being able to understand the importance and the consequence of the study
  • not being accomondated in an institution

You may not qualify if:

  • pneumonia acquired in a hospital
  • artificial respiration or other means for supporting respiration
  • allergic reaction because of skin contact with polymers
  • pregnancy or breast feeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Univeristy Hospital Aachen

Aachen, North Rhine Westfalia, 52074, Germany

Location

MeSH Terms

Conditions

Pneumonia

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Christian Cornelissen, MD

    RWTH Aachen University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 15, 2013

First Posted

March 26, 2013

Study Start

April 1, 2013

Primary Completion

February 1, 2014

Study Completion

February 1, 2014

Last Updated

September 23, 2015

Record last verified: 2015-09

Locations

DE(1)